Pandemic-related delays in endoscopic monitoring may not worsen inflammatory bowel disease outcomes, at least in the short term, according to research presented at the 2022 Crohn’s & Colitis Congress.
“The COVID-19 pandemic has been terrible, but it’s also presented us with a natural study design to see what happens if we disrupt the regular follow-up for IBD patients, which is, of course, not something we can do normally,” senior investigator Vitaliy Poylin, MD, an